Please login to the form below
big data
This page shows the latest big data news and features for those working in and with pharma, biotech and healthcare.
Current and future trends for developing digital medical communications
1. Big data to small data. ‘Big data’ is one of those buzz terms that has managed to endure for years without any sort of sturdy definition (I’m still a ... It is unclear if the volumes of data we deal with in medical communications would even
Latest news
-
Policy and public health: ML and AI in healthcare
A second challenge with today’s ML/AI platforms is that they are dependent on ‘big data’. ... The cost and time involved with aggregating huge volumes of data and then ‘cleaning’ the data are not insignificant and may delay attempts at
-
Bayer extends alliance with Evotec in women’s health
The programme will draw on Evotec’s ‘big data’ and genomics project with Celmatix, which was signed last year and focuses on preclinical stage drug candidates for women’s reproductive health
-
Four digital health trends set to reinvent and re-energise pharma
Personalise and improve products through big data. Alongside the benefits of real-time tracking outlined above, another key benefit of projects like Pfizer’s BlueSky is the vast amount of rich ... Once the data is aggregated, this will enhance the
-
Can AZ’s Imfinzi challenge Tecentriq in small cell lung cancer?
The big question is whether the CASPIAN data is compelling enough to challenge Roche’s PD-L1 inhibitor Tecentriq (atezolizumab), which was approved for first-line SCLC in the US in ... It also has stronger data in patients whose cancer has spread to
-
ViiV builds case for switching to its two-drug HIV combinations
The 48-week data are a big step forward in that regard, but analysts think that sales of GSK’s drug will only start to gather momentum after there is more ... In the meantime, Gilead looks set to continue to dominate the market with its three-drug
More from news
Approximately 19 fully matching, plus 99 partially matching documents found.
Latest Intelligence
-
Exploiting the value of data in pharma
How using data in an agile way can dramatically accelerate innovation and clinical trials. ... Big data can also help pharma companies identify the correct patients for specific drug trials through analysis of demographics, genetic information, patient
-
Has AI been the key to tackling the COVID-19 pandemic?
Indeed, a World Health Organization report released in February 2020 highlighted the important role that artificial intelligence and big data played in China’s initial response to the outbreak. ... If there is one thing AI excels in, it is analysing
-
AI: the smart money is on the smart thinking
In 2020, the amount of health data is expected to double every 73 days – and this Big Data both necessitates and supports the use of AI and machine learning. ... innovation, similar to the way in which Big Tech has impacted other industries.
-
The search for treatments for Parkinson’s disease
pharma firms are saying that ‘if you bring me a molecule with good phase 2 data, we would be very keen to license it’. ... This could involve wearable data, which is a big area of excitement right now.
-
Encouraging patient participation in real-world studies
By Bill Row, Bruce Capobianco and Maggie Adamski. With a variety of sources available, including electronic health records and devices to collect data directly from patients, real-world data (RWD) is ... With big data solutions advancing to the forefront
More from intelligence
Approximately 3 fully matching, plus 63 partially matching documents found.
Latest appointments
-
Christie Anbar appointed global healthcare lead at Ruder Finn
In her new role, Anbar will lead the company’s partnership with clients ranging from major biopharmaceutical companies to emerging biotech, tech and health data pioneers, as well as patient advocacy ... cutting-edge solutions and remaining ahead of
-
Global Gene Corp appoints new chief data and technology officer
I look forward to contribute to the success and health of GGC’s global customers, and lead a data and technology driven transformation of healthcare.”. ... I am looking forward to our journey together to create the defining company in this space
-
Shire adds Sara Mathew to board of directors
During her 12-year tenure at Dun &Bradstreet she helped transform the company from being a data provider to an innovative digital enterprise that leverages big data, insights and analytics.
-
Red Door Unlimited appoints senior consultants
Since then he has worked in technology and digital solutions, most recently co-founding a 'gamified big data' company called SocialCrunch, which helps agencies and their brands to understand their consumers ... working in communications, we are pleased
-
Apixio appoints new head of business development
Jonathan Murray joins healthcare data specialist from Aetna. Healthcare data firm Apixio has appointed Jonathan Murray as its new chief business development officer. ... Murray will lead strategic sales and business development activities at Apixio,
More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
Leveraging Data, Technology & Expertise to Solve Problems & Transform Healthcare
In the latest episode of Impetus Digital's Fireside Chat, Natalie Yeadon sat down with Tushar Pant, Consulting Executive in Healthcare at IBM, and discussed how technology is transforming healthcare. Among many other things, they explored how IBM is
-
Potential Benefits and Dangers of Big Data Analytics
We explore meaty topics such as mobile health technologies, cybersecurity risks of DNA testing, health data ownership, and privacy issues that have risen from the COVID-19 pandemic.
-
Patients are ready for virtual clinical trials, are you?
2.5 million people in the U.S. and the U.K. have generated valuable data about COVID-19. ... Scientists who specialise in big data research and epidemiology have developed a COVID Symptom Tracker app designed to collect important information on COVID-19
-
Impetus Digital Fireside Chat with Stephany Lapierre, Founder and CEO of Tealbook
Stephany is a highly coveted supply chain thought-leader, and one of the most influential minds in emerging data technologies. ... Currently, Tealbook is the only Big Data company that provides a self-enriching and self-maintaining mechanism to fix
-
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
The advancement in digital health technology, the availability of ‘big data’ and a focus on a value-for-patient economic environment are just some of the major contributing factors driving current
More from PMHub
Approximately 9 fully matching, plus 32 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Novacyt launches diagnostic test to differentiate between COVID-19 and flu
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- BMS eyes approval for second Opdivo combo in kidney cancer
- FDA hands BMS and bluebird bio a priority review for ide-cel
- Moderna inks R&D agreements with Vertex and Chiesi
- Using Artificial Intelligence to Transform Pharma
- Session 4: Systems Innovation Insight and Thinking
- Transforming Unstructured Healthcare Information into Real-World Evidence & Life Saving Insights
- UK COVID-19 vaccine ‘challenge trials’ could intentionally infect participants with virus
- Keytruda doubles five-year survival rate in NSCLC
- EMA fast-tracks review of bluebird bio’s LentiGlobin for sickle cell disease
PMHub
Six Degrees Medical Consulting
For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...
Latest intelligence
- Surviving cancer: a new era for patients
- Now more than ever, a shift in perspective is needed...
- Crisis? No problem!
- Issues planning & management for pharma spokespeople, by Andrew Smith...
- Are patient recruitment and retention rates rising or falling?
- First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Quick links
Infographics
